In this issue...
Did you know...
you can update your subscriptions for email communications from WBBA?
1. Go to www.washbio.org and select Member Center, Edit Profile from the top navigation panel
While you're there, you can update your profile fields too!
WBBA can help you recruit the talent needed to grow your organization?
1. Visit the online Career Center
your destination for exciting Life Science job opportunities is just a click away?
1. Visit the online Career Center
The work of the WBBA is dramatically extended by a network of business and scientific experts who are working to build a leading life sciences community globally. Please e-mail us at firstname.lastname@example.org if you are interested in volunteering on one of our important committees:
Headlines & Events from WBBA Members and Partners
The latest in life sciences
The Medical Device Manufacturers Association Issues June 2010 Washington Update
June 4, 2010: The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. MDMA plays a proactive role in helping to shape policy that impacts the medical device innovator. Read the June 2010 MDMA Washington Update to learn about their current activities.
Life Sciences and Global Health Drive Seattle to Kiplinger's #2 Best Places to Work
July 2010: Kiplinger, a Washington, D.C. based publisher of business forecasts and personal finance advice has named Seattle, with an 'economy ready for take-off', in their list of Best Places to Work. >>Read More
INHS Awarded $15.7 Million to Lead Collaborative Health IT “Beacon Community”
May 5, 2010: Inland Northwest Health Services (INHS), nationally recognized for the advancement and use of health information technology (HIT), in collaboration with a coalition of health care and public health organizations in eastern Washington and northern Idaho, has entered into a $15.7 million cooperative agreement with the U.S. Department of Health and Human Services (DHHS). >>Read More
FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
April 29, 2010: Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE(R) (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). PROVENGE is designed to induce an immune response against prostatic acid phosphatase (PAP), an antigen expressed in most prostate cancers, and is the first in a new therapeutic class known as autologous cellular immunotherapies.
"The FDA approval of PROVENGE is a testament to the courage of the patients and researchers who participated in our studies and is the culmination of nearly 15 years of research and development by our dedicated employees," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon.>> Read More
WBBA Offers Spring Course of 'From the Laboratory to Leadership'
From the Laboratory to Leadership turns science-minded managers into capable business leaders. That means they’ll get the core management skills they need to fully leverage your company’s human capital. This four-day program is developed exclusively for managers in scientific fields and is also beneficial to your non-science managers. Classes will be June 23, June 30, July 14, July 28. The program includes company and industry relevant case studies, practical and engaging exercises, down-loadable support tools for each session, and a manual designed to personalize the training for each participant. >>Learn more and register today.
Join the Clean Science Listserv
Biotech is an industry reliant on sterile, one use products, to ensure high quality research. This process generates a lot of waste. Is biotech doing everything it can to reduce waste, and increase recycling? Are we sacrificing the health of our planet for the health of people? Is there a way to create science that is clean and healthy for both the planet and for the people we are trying to heal? If you are interested in dialoguing about creating clean science, then join the group Clean Science (affiliated with WBBA). We would like to have participation from various groups in the lab including facilities, operations, and lab managers. Together, we can help heal people, progress science and have a healthy place to live. If you would like to join the new Clean Science listserv (and so that everyone has the opportunity to opt-in) please subscribe with these instructions: To subscribe - send an email to: email@example.com and in the message body type: Subscribe CleanScience Firstname Lastname (replacing your name). Please note that this goes in the body of the message and not in the Subject space. If you have questions, or would like to learn more, email Elizabeth Scallon at EScallon@vlstcorp.com.
WWFH/CAMI Rollout of the Battelle Study and Policy Platform
We Work for Health is assisting in the announcement of both a national survey by Battelle Research and the subsequent policy recommendations from that survey. Together, with the Council for American Medical Innovation (CAMI), they will unveil the results of the study at an event at Amgen’s Seattle campus on Monday, June 14, 2010.
Schedule of events:
Please RSVP to Charity Wright at firstname.lastname@example.org or at 206-323-3733.
Ultrasound: From Diagnosis to Therapy
The French-American Chamber of Commerce, in partnership with WBBA, is pleased to invite you to 'Ultrasound: From Diagnosis to Therapy', Tuesday, June 22, 2010 from 5:30 to 8:00 p.m. at the University of Washington, Seattle Campus.
The diiscussion will be moderated by Professor Matt O'Donnell Ph.D., Dean of Engineering at the University of Washington, and will feature the following panelists:
Seating limited to 48. Deadline for registration: June 11. >> Learn more and register today.
Institute of Translational Health Sciences 2010 Industry Day - SAVE THE DATE
Mark your calendar for September 22 to attend the 2010 ITHS Industry Day – an important interactive event designed to connect ITHS medical research institutions with industry and community partners. The half-day program will include informative networking opportunities and a discussion of issues vital to the success of translational health sciences. It will be an exciting morning dedicated to building new relationships and exploring collaborative ways to improve human health. Keynote Address by Dr. Barbara M. Alving, Director, National Center for Research Resources, National Institutes of Health.
Did you know...
Would you like to post a story in the Fall Issue of The Life Science Innovator?
Send your press release or announcement to WBBA's newsletter team by September 1, 2010 for publication date of September 15, 2010.
WBBA encourages our members to post their life science events to our website. Here is a sampling of the events that are being offered by our members: